| Date Filed | Type | Description |
| 08/18/2023 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 16,000 shares
@ $0 |
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2023 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 16,000 shares
@ $0 |
|
| 11/22/2022 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 45,455 shares
@ $0 |
|
| 04/25/2022 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 75,000 options to buy
@ $2.44, valued at
$183k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
3
| Weild IV David (Director) has filed a Form 3 on Scopus BioPharma Inc. |
| 05/04/2020 |
4
| Weild IV David (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.19, valued at
$219k
|
|
| 04/16/2020 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 75,000 options to buy
@ $4.66, valued at
$349.5k
|
|
| 10/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2019 |
4
| Weild IV David (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 200,000 options to buy
@ $1, valued at
$200k
|
|
| 11/09/2018 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 69,132 options to buy
@ $5.09, valued at
$351.9k
|
|
| 02/16/2018 |
4
| Weild IV David (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.01, valued at
$201k
|
|
| 11/28/2017 |
4
| Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2016 |
4
| Weild IV David (Director) has filed a Form 4 on PAVmed Inc.|
Txns:
| Granted 97,554 options to buy
@ $5, valued at
$487.8k
|
|